Natural reinfection with respiratory syncytial virus does not boost virus-specific T-cell immunity. - Wikidata - wikimedia - TriplyDB

Natural reinfection with respiratory syncytial virus does not boost virus-specific T-cell immunity.

Natural reinfection with respiratory syncytial virus does not boost virus-specific T-cell immunity.

http://www.wikidata.org/entity/Q40708973

about

Systems biology from virus to humans Human memory T cells: generation, compartmentalization and homeostasis Respiratory syncytial virus glycoprotein G interacts with DC-SIGN and L-SIGN to activate ERK1 and ERK2.Altered function in CD8+ T cells following paramyxovirus infection of the respiratory tract.Chinchilla and murine models of upper respiratory tract infections with respiratory syncytial virus.Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus.Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis.Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector The use of a neonatal mouse model to study respiratory syncytial virus infections.Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells.Protective and dysregulated T cell immunity in RSV infection Effectiveness of drug therapies to treat or prevent respiratory syncytial virus infection-related morbidity.Viral and host factors in human respiratory syncytial virus pathogenesis.Respiratory syncytial virus and innate immunity: a complex interplay of exploitation and subversion.IL-4Rα on CD4+ T cells plays a pathogenic role in respiratory syncytial virus reinfection in mice infected initially as neonates TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity.The host response and molecular pathogenesis associated with respiratory syncytial virus infection.Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design Respiratory syncytial virus: immunopathology and control.Molecular epidemiology and disease severity of respiratory syncytial virus in relation to other potential pathogens in children hospitalized with acute respiratory infection in Jordan.Translational sciences approach to RSV vaccine development.Central nervous system alterations caused by infection with the human respiratory syncytial virus.Reduced activation and proliferation of human lymphocytes exposed to respiratory syncytial virus compared to cells exposed to influenza virus.Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection.Novel recombinant DNA vaccine candidates for human respiratory syncytial virus: Preclinical evaluation of immunogenicity and protection efficiency.Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection.A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus.Antibody-Induced Internalization of the Human Respiratory Syncytial Virus Fusion Protein.Respiratory syncytial virus detection in cells and clinical samples by using three new monoclonal antibodies.Infection of mice with respiratory syncytial virus during neonatal life primes for enhanced antibody and T cell responses on secondary challenge.Differential response of human naive and memory/effector T cells to dendritic cells infected by respiratory syncytial virus.Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis.The CD8 T Cell Response to Respiratory Virus Infections.

P2860

Q26798272-241930DD-DB7D-4FC8-A204-6A1BA113B22B Q26851748-45DC2E26-C733-4E9C-AC65-AA0BC57F7E7F Q30425776-272986EE-7996-4F67-BB58-E0299E599456 Q33737608-0F0554CF-1F14-4D44-8184-5A15006C7D68 Q33780476-EBA4BD65-D3D1-44A4-9ADE-B5108C50D5FE Q33813095-182F0321-6CD1-4805-AD45-617D0AE4F88E Q33964142-28ABEAF2-A252-479F-B4D6-EE3E0E8E7E25 Q34224973-63963C5A-9C98-470B-95E2-6B16200D8E48 Q34302198-4159FEB3-57D5-4E2E-A001-8432C674E44F Q34549253-E23477A7-BF4A-464D-9DAB-158E02948E9E Q34791209-84609459-624F-435F-BF2E-17D5B06053E8 Q34964939-4CA1815A-6F06-4F7D-9A2F-1A207F2872AC Q35548189-F66C345F-75E2-4593-A3FC-A859760EB83E Q36483836-601A64F8-B917-4DF6-BB47-130657CCE8E9 Q36530226-C44EDDFA-DCA6-4134-A368-C35BC017679F Q36850478-EF43FAB9-D932-466A-976E-AECBE95DBA3E Q37188620-82159020-06D1-4236-8410-88233554501C Q37263779-1530BE2C-E9E3-4734-9CA9-5FAB78857DE0 Q37729137-AC7970D3-6000-49B5-A2C3-C2A5D4D33F4C Q37754763-F4D2C5BF-2F94-4425-83E4-35647732E5E0 Q37858606-FBF9C4E9-7120-4837-966D-71F4EA8C90B7 Q38140040-FEB366E4-8DA4-4F60-AF38-252501DA6E57 Q38260281-9743C7FB-7EC1-4DF3-9E31-89F560B38D91 Q38600929-2BAD9279-71E7-4295-B81B-0B0F94FA548B Q38671952-C7981E16-1019-4EF6-8EDB-493DF6FA8991 Q38921013-067E26DA-472F-441B-9D02-D7EB25DEA91E Q39027049-1BAE2194-2C45-4062-AAAE-567871A650E6 Q39362187-F855A76F-567C-4591-84C4-A1055578B8D4 Q40216566-0D55F559-A6C2-45D2-8EDD-24CBCF1DC303 Q42260469-EB41EE19-D40B-48EA-8087-8132EF8451EC Q44737130-CF6B6510-B117-429A-A4C7-E0CA1D0B18E0 Q45189462-544D83ED-04F3-4603-A5A7-47A81F9ACD44 Q54231427-B51F60FF-69A4-411E-B434-6058C9C4D9A6 Q55101403-2FCD0515-7288-4891-ADF1-3F24540550AE

P2860

Natural reinfection with respiratory syncytial virus does not boost virus-specific T-cell immunity.

http://www.wikidata.org/entity/Q40708973

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Natural reinfection with respi ...... irus-specific T-cell immunity.

@en

type

label

Natural reinfection with respi ...... irus-specific T-cell immunity.

@en

prefLabel

Natural reinfection with respi ...... irus-specific T-cell immunity.

@en

P1433

Q40708973-A6A288B6-32A1-4451-BFD1-8E276CF4E7A4

P1476

Q40708973-FB9ED125-D27C-49EF-9A29-5FD84B94F970

P2093

Q40708973-18A795DA-B9CA-4354-B378-2270D63DE009

Q40708973-297076F2-A02B-4145-8BF3-E1DE9A86D0B6

Q40708973-5226ADE6-EC46-48F1-96C7-0863FE51BF8D

Q40708973-6F71D656-CA4A-481E-9B5F-C88E6ED78562

Q40708973-95D6EB6B-3380-4902-A908-BD04D7F0EFA0

Q40708973-9F99FD61-F3CE-4898-A51D-35483150BCBA

Q40708973-B439456A-21CD-4170-AF08-7380B261464F

Q40708973-C29431F6-1D2C-4116-9F76-A8BD724851A1

Q40708973-CA129A31-1A63-4304-9FFE-B8E24C59F216

Q40708973-EF153549-D479-456C-8275-F025A8D3EA22

P2860

Q40708973-0EA7B59E-9BFA-4C9D-ABF2-BCACA47B75B2

Q40708973-1EC69E7D-846F-42CA-B422-C56565902D6D

Q40708973-2410BDDB-7469-41E7-8DB2-06DD863AB751

Q40708973-3B19E82B-2F0A-4DE3-9474-D415F3E8E674

Q40708973-3DF51935-E97F-4239-A1D5-1828E6A55F77

Q40708973-4005FE8D-5ED2-49FE-82E3-51ECD6793613

Q40708973-406F1219-164C-4A0E-B504-EAD6821731CC

Q40708973-4569DEB7-EFC8-448A-A567-AD8690D4800B

Q40708973-57816E7F-E848-4A95-B2D4-94A4CDE30439

Q40708973-66B54E12-EA9A-4291-8831-178F6661F9C3

P2888

Q40708973-2F8B79AC-75E1-4E95-B031-2E89A631EB0D

P304

Q40708973-E7426D21-B0CA-4714-B320-7B92AAF6B5A1

P31

Q40708973-3950259B-683A-45A8-B028-BF3DB371A28A

P356

Q40708973-1704D55E-5AAC-4635-8D13-665C40172859

P407

Q40708973-15421064-D349-42EC-9D74-3443311B38AD

P433

Q40708973-856D8F61-B87D-44A3-A4BF-0709712F8C63

P478

Q40708973-56A24CC5-D0C7-414E-B858-E7E688D26989

P577

Q40708973-13D9C9B9-A7CE-4A32-8052-763293AC2007

P5875

Q40708973-186E086F-3CF8-4E7F-B4FC-198FED5DA79A

P6179

Q40708973-2A4251FC-7399-4C1A-B2EF-158091B91BDC

P698

Q40708973-551B3031-63F5-403C-A5BE-600C7D260229

P356

00006450-200209000-00009

P1433

Pediatric Research

P1476

Natural reinfection with respi ...... irus-specific T-cell immunity.

@en

P2093

Annemieke Kavelaars

http://www.w3.org/2001/XMLSchema#string

Cobi J Heijnen

http://www.w3.org/2001/XMLSchema#string

Frank Brus

http://www.w3.org/2001/XMLSchema#string

Jan L L Kimpen

http://www.w3.org/2001/XMLSchema#string

Jorien Versteegh

http://www.w3.org/2001/XMLSchema#string

Jos M Th Draaisma

http://www.w3.org/2001/XMLSchema#string

Louis Bont

http://www.w3.org/2001/XMLSchema#string

Martha Pekelharing-Berghuis

http://www.w3.org/2001/XMLSchema#string

Ronnie A A M van Diemen-Steenvoorde

http://www.w3.org/2001/XMLSchema#string

Wendy T N Swelsen

http://www.w3.org/2001/XMLSchema#string

P2860

Natural killer cells in antiviral defense: function and regulation by innate cytokines.

Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.

Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus

Respiratory syncytial virus infections within families.

Pathogenesis of respiratory syncytial virus vaccine-augmented pathology.

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine.

Cell-mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease.

Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis.

Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection.

Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997.

P2888

00006450-200209000-00009

P304

363-367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1203/00006450-200209000-00009

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2002-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11193911

http://www.w3.org/2001/XMLSchema#string

P6179

1049425097

http://www.w3.org/2001/XMLSchema#string

P698

12193668

http://www.w3.org/2001/XMLSchema#string